Dermoceutic: a new concept at the crossroads
Dermatidyss® is the first ingredient emerging from Abyss Ingredients’ new concept Dermoceutic. This new natural bioactive ingredient soothes skin and mind of people with sensitive and/or atopic-prone skin.
A recent randomised, double-blind, placebo-controlled clinical study* has demonstrated the following effects, at only 600 mg/day:
• Significant reduction of skin roughness
• Significant improvement of quality of life related to atopic dermatitis
• 73% of participants reported a fast-action of Dermatidyss® with the first effects felt in just 11 days!
Meet us at stand D10 de Trades
